Table 1.
Baseline characteristics of the included patients
| ESD group (39) | MBM group (60) | ESE (36) | P value | |
|---|---|---|---|---|
| Gender | 0.431 | |||
| Male | 22 (56.4%) | 38 (63.3%) | 18 (50%) | |
| Female | 17 (43.6%) | 22 (36.7%) | 18 (50%) | |
| Median age | 57.6 | 58.2 | 59.1 | > 0.05 |
| Tumor site | 0.584 | |||
| Esophagus | 16 (41.0%) | 29 (48.3%) | 19 (52.8%) | |
| Stomach | 23 (58.9%) | 31 (51.7%) | 17 (47.2%) | |
| Layer of origin | 0.184 | |||
| MM | 15 (38.5%) | 28 (46.7%) | 10 (27.8%) | |
| SM | 24 (61.5%) | 32 (53.3%) | 26 (72.2%) | |
| Histologic diagnosis | 0.08 | |||
| GIST | 14 (35.9%) | 13 (21.7%) | 16 (44.4%) | |
| Leiomyoma | 23 (58.9%) | 39 (65%) | 19 (52.7%) | |
| others | 2 (5.1%) | 8 (13.3%) | 1 (2.7%) | |
| Tumor size | 0.001 | |||
| Tumor < 15 mm | 14 (35.9%) | 42 (70%) | 14 (38.9%) | |
| 15 mm ≤ Tumor< 30 mm | 25 (64.1%) | 18 (30%) | 22 (61.1%) |